Navigation Links
TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet
Date:8/31/2008

Landmark ARB trial investigated Micardis(R) (telmisartan) against placebo in reducing the composite endpoint of cardiovascular death, myocardial infarction, stroke and hospitalization for congestive heart failure in ACE inhibitor intolerant high-risk patients receiving current standard of care

RIDGEFIELD, Conn., Aug. 31 /PRNewswire/ -- The primary results of the TRANSCEND(TM)* trial demonstrated that treatment with MICARDIS(R) (telmisartan) 80mg in patients receiving current standard of care resulted in an 8% reduction in the composite endpoint of cardiovascular death, myocardial infarction, stroke and hospitalization for congestive heart failure. This reduction was not statistically significant (p=0.216; HR 0.92) compared to patients receiving placebo in addition to current standard of care.(1) Results of the main secondary endpoint of TRANSCEND as pre-specified in the statistical plan demonstrated that telmisartan significantly reduced the risk of cardiovascular death, myocardial infarction and stroke in high-risk cardiovascular patients by 13% compared with those patients already receiving current standard of care (p=0.048).(1) This risk reduction was achieved despite a high proportion of patients receiving proven therapies such as statins, anti-platelet agents or beta blockers. The main secondary endpoint of TRANSCEND mirrors the primary endpoint of the landmark HOPE trial.(2) A post-hoc analysis to adjust for multiplicity and overlap with primary endpoint showed a p-value of 0.068.(1) The results were presented today at the annual meeting of the European Society of Cardiology in Munich, Germany and published online in The Lancet.

In high-risk patients who cannot tolerate an angiotensin-converting enzyme (ACE) inhibitor, the TRANSCEND trial was designed to investigate potential cardiovascular risk reduction benefits using the second-generation angiotensin II receptor blocker (ARB) telmisartan. Telmisartan was compared to placebo on top of
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ITY, Nov. 27 Booth - 364...E: VAR ), a premier supplier of X-ray tubes and ...ts full range of detectors at the RSNA Annual Meet..., 2009. Varian will also be exhibiting X-ray tube...cialized cancer treatment technologies. ,, Var...
(Date:11/25/2009)... Calif., Nov. 25 Praxis Electronic...the American Academy of Family Physicians, (AAFP) ...isfaction Survey for improving medical quality, he...ical for new ARRA Stimulus legislation. Praxis als... a positive effect in determining their salary. Fi...
(Date:11/25/2009)...J., Nov. 25 Pharmasset, ...ical company committed to discovering, developing ...ections, reported financial results for the fiscal...009 Pharmasset held $58.4 million in cash, cash eq...line Update and 2009 Highlights ,, RG7128 ,...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10InVitria Reports Successful Cell Culture Performance of Zap CHO a Defined and Cost Effective CHO Cell Culture Media Supplement 60242 1InVitria Reports Successful Cell Culture Performance of Zap CHO a Defined and Cost Effective CHO Cell Culture Media Supplement 60242 2Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 1Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 2Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 3Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 4Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 5Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 6bioMerieux Adds Methicillin resistant Staphylococcus aureus 28MRSA 29 Screening Tool to its Arsenal 5786 1bioMerieux Adds Methicillin resistant Staphylococcus aureus 28MRSA 29 Screening Tool to its Arsenal 5786 2bioMerieux Adds Methicillin resistant Staphylococcus aureus 28MRSA 29 Screening Tool to its Arsenal 5786 3bioMerieux Adds Methicillin resistant Staphylococcus aureus 28MRSA 29 Screening Tool to its Arsenal 5786 4
(Date:11/27/2009)...wire-USNewswire/ -- Preventing disease is the goal...ry year, new vaccines are being added to assist in...unity for the same period of time? And, if not, wh...mmunity strong? ,, In this month,s issue of P...Pediatrics, Michael Pichichero MD, Director of the...
(Date:11/27/2009)..., economic burdens, study predicts , , F...eople with diabetes in the United States is expect...redicts. , That would bring the total by 2034 t...rom 23.7 million today. , , At the same time, th...e, the study also warns, rising from an estimated ...
(Date:11/27/2009)...ive anatomy education apps from Modality and Lippi...s learning opportunities for iPhone and iPod touch...ember 27, 2009 -- Modality, Inc. and Lippincott ...s Kluwer Health, today announced the availability ...re. Clemente’s Anatomy, Rohen’s Photog...
(Date:11/26/2009)... to strains or worse , , THURSDAY, Nov. ...with stuffing your turkey full to bursting, but yo...itcase as you pack for holiday trips. , More th...ital emergency rooms, doctors, offices, clinics an...uries, such as muscle strains, pulls and tears, ac...
(Date:11/26/2009)...ons announces a highly effective and unconventiona...to make an economic recovery. , ...he type of challenge that could send ailing holida...vid Benton, business growth expert and author of t...The Rfactor Intensive . “Fear is one of th...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2
... PITTSBURGH, April 21 The longer women breastfeed...nd cardiovascular disease, report University of Pi...ay issue of Obstetrics & Gynecology . , "Heart...hwarz, M.D., M.S., assistant professor of medicine...
...WILMINGTON, Del., April 8 Today, the U.S. Food an...ugs Advisory Committee (PDAC) conducted a review o... applications (sNDA) for SEROQUEL XR (quetiapine f...ory Committee concluded: , , , SEROQUEL...
... Maintaining a healthy body weight is good news fo...ars today in the International Journal of Epidemi...ributor to global warming, a lean population, such...se to that seen in the USA today), according to Ph...
...Satellite Healthcare Senior Director of Quality Ho...VIEW, Calif., April 20 Satellite Healthcare, one ...ney dialysis services and a major sponsor of nephr...ner on Thursday, April 23 at Yoshi,s Jazz Club in ...
...NEWTOWN, Pa., April 20 The managing director of P...ny, has been invited to speak at the 45th Annual D...Diego. , , Henry W. Singer will be present a talk...niting professionals from all facets within the in...
..., Bioinformatics researchers from UC San Diego jus...an cells switch from "proliferation mode" to "spec...from the Jacobs School of Engineering,s bioenginee...could also improve our understanding of how organs...
Other Medicine News:Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 2Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 3Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 4Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 5Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 6Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 7Health News:Renal Dietitian, Linda McCann, Receives 2009 Champion of Hope Award 2Health News:How cells change gears: New insights published in Nature Genetics 2Health News:How cells change gears: New insights published in Nature Genetics 3
Single-Piece Intraocular Lens with haptic eyelets
NaturaLens™ Series Hydrophobic Acrylic Intraocular Lens (Refractive and Bifocal)
STABIBAG Hydrophilic Acrylic Lens
Raysoft Foldable Intraocular Lens
Medicine Products: